Investment List

53 investments found

Date	Investor	Investor*	Target	Round	Group	Amount (USD)	Country
2024-12-23	OrbiMed	OrbiMed	Ikena Oncology	Post-IPO Equity	6 Exit / Public	—
2024-12-23	OrbiMed	OrbiMed	Rapt Therapeutics	Post-IPO Equity	6 Exit / Public	—
2024-12-20	OrbiMed	OrbiMed	Aadi Bioscience	Post-IPO Equity	6 Exit / Public	—
2024-12-19	OrbiMed	OrbiMed	Ottimo Pharma	Series A	3 Early Growth	—
2024-12-18	OrbiMed	OrbiMed	SiteOne Therapeutics	Series C	4 Growth	—
2024-12-11	OrbiMed	OrbiMed	Angitia Biopharmaceuticals	Series C	4 Growth	—
2024-11-25	OrbiMed	OrbiMed	ADCendo	Series B	3 Early Growth	—
2024-11-20	OrbiMed	OrbiMed	Forte Biosciences	Post-IPO Equity	6 Exit / Public	—
2024-11-18	OrbiMed	OrbiMed	Avenzo Therapeutics	Series A	3 Early Growth	—
2024-11-12	OrbiMed	OrbiMed	Alentis Therapeutics	Series D	4 Growth	—
2024-11-04	OrbiMed	OrbiMed	Lomond Therapeutics	Venture Round	7 Other	—
2024-10-30	OrbiMed	OrbiMed	Leal Therapeutics	Venture Round	7 Other	—
2024-10-25	OrbiMed	OrbiMed	enGene	Post-IPO Equity	6 Exit / Public	—
2024-10-02	OrbiMed	OrbiMed	Triveni Bio	Series B	3 Early Growth	—
2024-09-30	OrbiMed	OrbiMed	Poxel	Post-IPO Debt	6 Exit / Public	—
2024-09-23	OrbiMed	OrbiMed	Kapiva	Series C	4 Growth	—
2024-09-09	OrbiMed	OrbiMed	Candid Therapeutics	Series A	3 Early Growth	—
2024-08-05	OrbiMed	OrbiMed	MBX Biosciences	Series C	4 Growth	—
2024-07-25	OrbiMed	OrbiMed	Chemomab	Post-IPO Equity	6 Exit / Public	—
2024-07-24	OrbiMed	OrbiMed	Brenig Therapeutics	Series A	3 Early Growth	—
2024-07-23	OrbiMed	OrbiMed	Magenta Medical	Venture Round	7 Other	—
2024-07-16	OrbiMed	OrbiMed	Scorpion Therapeutics	Series C	4 Growth	—
2024-07-16	OrbiMed	OrbiMed	Asceneuron	Series C	4 Growth	—
2024-06-25	OrbiMed	OrbiMed	Exsilio Therapeutics	Series A	3 Early Growth	—
2024-06-14	OrbiMed	OrbiMed	Disc Medicine	Post-IPO Equity	6 Exit / Public	—
2024-05-02	OrbiMed	OrbiMed	Corvus Pharmaceuticals	Post-IPO Equity	6 Exit / Public	—
2024-04-30	OrbiMed	OrbiMed	TriSalus Life Sciences	Post-IPO Debt	6 Exit / Public	—
2024-04-24	OrbiMed	OrbiMed	Sparrow Pharmaceuticals	Venture Round	7 Other	—
2024-04-18	OrbiMed	OrbiMed	Shenluo Medical	Series B	3 Early Growth	—
2024-04-16	OrbiMed	OrbiMed	Cullinan Therapeutics	Post-IPO Equity	6 Exit / Public	—
2024-04-03	OrbiMed	OrbiMed	Alterome Therapeutics	Series B	3 Early Growth	—
2024-03-27	OrbiMed	OrbiMed	Avalo Therapeutics	Post-IPO Equity	6 Exit / Public	—
2024-03-25	OrbiMed	OrbiMed	Nkarta Therapeutics	Post-IPO Equity	6 Exit / Public	—
2024-03-25	OrbiMed	OrbiMed	Q32 Bio	Post-IPO Equity	6 Exit / Public	—
2024-03-21	OrbiMed	OrbiMed	Mirador Therapeutics	Series A	3 Early Growth	—
2024-03-20	OrbiMed	OrbiMed	Capstan Therapeutics	Series B	3 Early Growth	—
2024-03-19	OrbiMed	OrbiMed	Fate Therapeutics	Post-IPO Equity	6 Exit / Public	—
2024-03-19	OrbiMed	OrbiMed	Geron	Post-IPO Equity	6 Exit / Public	—
2024-03-11	OrbiMed	OrbiMed	Lexicon Pharmaceuticals	Post-IPO Equity	6 Exit / Public	—
2024-03-06	OrbiMed	OrbiMed	Sionna Therapeutics	Series C	4 Growth	—
2024-03-06	OrbiMed	OrbiMed	BIOMx	Post-IPO Equity	6 Exit / Public	—
2024-02-26	OrbiMed	OrbiMed	Pinnacle Medicines	Series A	3 Early Growth	—
2024-02-15	OrbiMed	OrbiMed	Arcatron Mobility	Venture Round	7 Other	—
2024-02-13	OrbiMed	OrbiMed	ProfoundBio	Series B	3 Early Growth	—
2024-02-13	OrbiMed	OrbiMed	BioAge Labs	Series D	4 Growth	—
2024-02-08	OrbiMed	OrbiMed	Mineralys Therapeutics	Post-IPO Equity	6 Exit / Public	—
2024-02-08	OrbiMed	OrbiMed	DIH Technology Inc.	Post-IPO Equity	6 Exit / Public	—
2024-02-02	OrbiMed	OrbiMed	Tyra Biosciences	Post-IPO Equity	6 Exit / Public	—
2024-01-19	OrbiMed	OrbiMed	Edgewise Therapeutics	Post-IPO Equity	6 Exit / Public	—
2024-01-16	OrbiMed	OrbiMed	Noctrix Health	Series C	4 Growth	—
2024-01-04	OrbiMed	OrbiMed	OnCusp Therapeutics	Series A	3 Early Growth	—
2024-01-03	OrbiMed	OrbiMed	ENYO Pharma	Series C	4 Growth	—	FR
2024-01-02	OrbiMed	OrbiMed	BlossomHill Therapeutics	Series B	3 Early Growth	—